Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acumen Pharmaceuticals, Inc.

1.23
+0.02001.65%
Post-market: 1.240.0100+0.81%16:41 EST
Volume:203.33K
Turnover:249.34K
Market Cap:73.90M
PE:-0.89
High:1.27
Open:1.19
Low:1.18
Close:1.21
Loading ...

Promising US Penny Stocks To Consider In January 2025

Simply Wall St.
·
25 Jan

Acumen announces Phase 1 INTERCEPT-AD study publication

TIPRANKS
·
09 Jan

Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer’s Disease Publication of the Company’s Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findings

GlobeNewswire
·
09 Jan

Analysts Offer Insights on Healthcare Companies: Acumen Pharmaceuticals (ABOS) and Immix Biopharma, Inc. (IMMX)

TIPRANKS
·
06 Jan

I-Mab Leads Our Spotlight On 3 US Penny Stocks

Simply Wall St.
·
04 Dec 2024

Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

GlobeNewswire
·
27 Nov 2024

Acumen Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $12 From $14

THOMSON REUTERS
·
13 Nov 2024

Bank of America Securities Keeps Their Buy Rating on Acumen Pharmaceuticals (ABOS)

TIPRANKS
·
13 Nov 2024

Acumen Pharmaceuticals Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Nov 2024

Acumen Pharmaceuticals Inc (ABOS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

GuruFocus.com
·
13 Nov 2024

Q3 2024 Acumen Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
13 Nov 2024

Acumen Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
12 Nov 2024

Acumen Pharmaceuticals Q3 2024 GAAP EPS $(0.50) Misses $(0.36) Estimate

Benzinga
·
12 Nov 2024

BRIEF-Acumen Pharmaceuticals, Inc. Q3 Income From Operations USD -32.265 Million

Reuters
·
12 Nov 2024

Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights

GlobeNewswire
·
12 Nov 2024

Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

GlobeNewswire
·
12 Nov 2024